| URL: | http://bioinf.charite.de/superdrug |
| Full name: | A one stop resource for approved/marketed drugs. |
| Description: | SuperDRUG2 database is a unique, one-stop resource for approved/marketed drugs, containing more than 4,600 active pharmaceutical ingredients. We annotated drugs with regulatory details, chemical structures (2D and 3D), dosage, biological targets, physicochemical properties, external identifiers, side-effects and pharmacokinetic data. Different search mechanisms allow navigation through the chemical space of approved drugs. A 2D chemical structure search is provided in addition to a 3D superposition feature that superposes a drug with ligands already known to be found in the experimentally determined protein-ligand complexes. For the first time, we introduced simulation of "physiologically-based" pharmacokinetics of drugs. Our interaction check feature not only identifies potential drug-drug interactions but also provides alternative recommendations for elderly patients. |
| Year founded: | 2005 |
| Last update: | 2018.2.7 |
| Version: | |
| Accessibility: |
Accessible
|
| Country/Region: | Germany |
| Data type: | |
| Data object: | |
| Database category: | |
| Major species: | |
| Keywords: |
| University/Institution: | Institute of Biochemistry Charity |
| Address: | Berlin Center of Genome Based Bioinformatics, 3D Datamining Group, Institute of Biochemistry Charité, Monbijoustrasse 2, 10117 Berlin, Germany |
| City: | Berlin |
| Province/State: | |
| Country/Region: | Germany |
| Contact name (PI/Team): | Robert Preissner |
| Contact email (PI/Helpdesk): | robert.preissner@charite.de |
|
SuperDRUG2: a one stop resource for approved/marketed drugs. [PMID: 29140469]
Regular monitoring of drug regulatory agency web sites and similar resources for information on new drug approvals and changes to legal status of marketed drugs is impractical. It requires navigation through several resources to find complete information about a drug as none of the publicly accessible drug databases provide all features essential to complement in silico drug discovery. Here, we propose SuperDRUG2 (http://cheminfo.charite.de/superdrug2) as a comprehensive knowledge-base of approved and marketed drugs. We provide the largest collection of drugs (containing 4587 active pharmaceutical ingredients) which include small molecules, biological products and other drugs. The database is intended to serve as a one-stop resource providing data on: chemical structures, regulatory details, indications, drug targets, side-effects, physicochemical properties, pharmacokinetics and drug-drug interactions. We provide a 3D-superposition feature that facilitates estimation of the fit of a drug in the active site of a target with a known ligand bound to it. Apart from multiple other search options, we introduced pharmacokinetics simulation as a unique feature that allows users to visualise the 'plasma concentration versus time' profile for a given dose of drug with few other adjustable parameters to simulate the kinetics in a healthy individual and poor or extensive metabolisers. |
|
SuperDrug: a conformational drug database. [PMID: 15691861]
MOTIVATION: Different resources exist for experimentally determined and computed three-dimensional (3D)-structures of low molecular weight structures but for approved drugs, no free, publicly accessible source of 3D-structures and conformers is available. Furthermore, for selection purposes or for correlation of structural similarity with medical application, the assignment of the Anatomical Therapeutic Chemical (ATC) classification codes to each structure according to the WHO-scheme would be desirable. |